Harlem Hospital Center, branded as NYC Health + Hospitals/Harlem, is a 272-bed, public teaching hospital affiliated with Columbia University. It is located at 506 Lenox Avenue in Harlem, Manhattan, New York City and was founded in 1887.

There are 272 beds in Harlem Hospital Ctr./Columbia University CRS (Gordin CTU).

During the past decade, Harlem Hospital Ctr./Columbia University CRS (Gordin CTU) conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 1 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)" #1 collaborator was "Chiron Corporation" with 2 trials as a collaborator, "Bayer" with 1 trials as a collaborator, "Community Programs for Clinical Research on AIDS" with 1 trials as a collaborator, "Global Alliance for TB Drug Development" with 1 trials as a collaborator and "Sanofi" with 1 trials as a collaborator. Other collaborators include -5 different institutions and companies that were collaborators in the rest 5 trials.

According to Clinical.Site data, the most researched conditions in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)" are "HIV Infections" (7 trials), "Anus Neoplasms" (1 trials), "Pulmonary Tuberculosis" (1 trials) and "Tuberculosis" (1 trials). Many other conditions were trialed in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)" in a lesser frequency.

Most popular intervention types in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)" are "Drug" (5 trials). Other intervention types were less common.

The name of intervention was led by "Antiretroviral Regimens" (1 trials), "IL-2" (1 trials), "Moxifloxacin (with rifampin, pyrazinamide, and ethambutol)" (1 trials), "Recombinant interleukin-2 (rIL-2)" (1 trials) and "isoniazid" (1 trials). Other intervention names were less common.

The vast majority of trials in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)" are 9 trials for "All" genders.

Currently, there are NaN active trials in "Harlem Hospital Ctr./Columbia University CRS (Gordin CTU)". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 9 completed trials in Harlem Hospital Ctr./Columbia University CRS (Gordin CTU), undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Harlem Hospital Ctr./Columbia University CRS (Gordin CTU), 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".